Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363706 | SCV001559830 | uncertain significance | not provided | 2021-08-28 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with tyrosine at codon 432 of the ELP1 protein (p.His432Tyr). The histidine residue is weakly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is present in population databases (rs773228197, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002493856 | SCV002792351 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2022-01-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001836365 | SCV002082134 | uncertain significance | Familial dysautonomia | 2021-10-13 | no assertion criteria provided | clinical testing |